Schlafapnoe & Schlaganfall

Matthias Boentert

doi:10.1055/s-0038-1626084

Schlaf, Table of Contents

Schlaf 2014; 03(01): 22-25
DOI: 10.1055/s-0038-1626084

Review

Schattauer GmbH

Schlafapnoe & Schlaganfall

Matthias Boentert

¹Universitätsklinikum Münster, Dept. für Neurologie, Klinik für Schlafmedizin und Neuromuskuläre Erkrankungen, Email: matthias.boentert@ukmuenster.de

› Author Affiliations

Abstract

Die Obstruktive Schlafapnoe (OSA) ist ein klinisch hoch relevanter Risikofaktor für den ischämischen Schlaganfall. Patienten mit OSA haben ein signifikant erhöhtes Risiko, eine arterielle Hypertonie, Vorhofflimmern, eine koronare Herzerkrankung und eine Herzinsuffizienz zu entwickeln, die allesamt zum ischämischen Schlaganfall prädisponieren. Unabhängig von bekannten kardiovaskulären Risikofaktoren erhöht das Vorliegen einer OSA das relative Risiko für den ischämischen Insult erheblich. In der Akutphase nach einem ischämischen Schlaganfall oder einer intrakraniellen Blutung treten schlafbezogene Atmungsstörungen mit hoher Prävalenz auf.

Full Text

References

Literatur
1 Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320 (7233) 479-482.
2 Logan AG, Perlikowski SM, Mente A. et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19 (12) 2271-2277.
3 Mehra R. et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (08) 910-916.
4 Gami AS, Pressman G, Caples SM. et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110 (04) 364-367.
5 Chasens ER. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ 2007; 33 (03) 475-482.
6 Clarenbach CF, West SD, Kohler M. Is obstructive sleep apnea a risk factor for diabetes?. Discov Med 2011; 12 (62) 17-24.
7 West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006; 61 (11) 945-950.
8 Punjabi NM. et al. Resnick, Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (06) 521-530.
9 Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J 2006; 99 (01) 58-67 quiz 68–9, 81.
10 Nachtmann A, Stang A, Wang YM. et al. Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients. Atherosclerosis 2003; 169 (02) 301-307.
11 Dziewas R, Ritter M, Usta N. et al. Atherosclerosis and obstructive sleep apnea in patients with ischemic stroke. Cerebrovasc Dis 2007; 24 (01) 122-126.
12 Arzt M, Young T, Finn L. et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172 (11) 1447-1451.
13 Redline S, Yenokyan G, Gottlieb DJ. et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010; 182 (02) 269-277.
14 Yaggi HK, Concato J, Kernan WN. et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353 (19) 2034-2041.
15 Munoz R, Duran-Cantolla J, Martinez-Vila E. et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006; 37 (09) 2317-2321.
16 Turkington PM, Bamford J, Wanklyn P, Elliott MW. Prevalence and predictors of upper airway obstruction in the first 24 hours after acute stroke. Stroke 2002; 33 (08) 2037-2042.
17 Good DC. et al. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27 (02) 252-259.
18 Mansukhani MP. et al. Worse outcome after stroke in patients with obstructive sleep apnea: an observational cohort study. J Stroke Cerebrovasc Dis 2011; 20 (05) 401-405.
19 Sahlin C, Sandberg O, Gustafson Y. et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008; 168 (03) 297-301.
20 Jones SB, Sen S, Lakshminarayan K, Rosamond WD. Post-stroke Outcomes Vary by Pathogenic Stroke Subtype in The Atherosclerosis Risk in Communities Study. Stroke. 2013
21 Rola R. et al. Sleep disorderd breathing and recurrence of cerebrovascular events, case-fatality, and functional outcome in patients with ischemic stroke or transient ischemic attack. J Physiol Pharmacol 2008; 59: 615-621.
22 Minnerup J, Ritter MA, Wersching H. et al. Continuous positive airway pressure ventilation for acute ischemic stroke: a randomized feasibility study. Stroke 2012; 43 (04) 1137-1139.
23 Bravata DM, Concato J, Fried T. et al. Continuous positive airway pressure: evaluation of a novel therapy for patients with acute ischemic stroke. Sleep 2011; 34 (09) 1271-1277.
24 Parra O. et al. Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial. Eur Respir J 2011; 37 (05) 1128-1136.
25 Ryan CM. et al. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 2011; 42 (04) 1062-1067.